{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:18:53Z","timestamp":1757704733368},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T00:00:00Z","timestamp":1493942400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10067-017-3638-1","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T10:49:54Z","timestamp":1493981394000},"page":"1281-1288","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MISS questionnaire in French version: a good tool for children and parents to assess methotrexate intolerance"],"prefix":"10.1007","volume":"36","author":[{"given":"Aur\u00e9lie","family":"Chausset","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiphaine","family":"Fargeix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Echaubard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Duquesne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Desjonqu\u00e8res","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Freychet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Merlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"key":"3638_CR1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1053\/berh.2002.0234","volume":"16","author":"KJ Murray","year":"2002","unstructured":"Murray KJ, Lovell DJ (2002) Advanced therapy for juvenile arthritis. Best Pract Res Clin Rheumatol 16:361\u2013378","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3638_CR2","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3899\/jrheum.120110","volume":"39","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Ringold S, Davis TE et al (2012) Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry. J Rheumatol 39:1867\u20131874. doi:\n10.3899\/jrheum.120110","journal-title":"J Rheumatol"},{"key":"3638_CR3","first-page":"2501","volume":"31","author":"O Ortiz-Alvarez","year":"2004","unstructured":"Ortiz-Alvarez O, Morishita K, Avery G et al (2004) Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis. J Rheumatol 31:2501\u20132506","journal-title":"J Rheumatol"},{"key":"3638_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00296-004-0537-y","volume":"25","author":"T Niehues","year":"2005","unstructured":"Niehues T, Horneff G, Michels H et al (2005) Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria. Rheumatol Int 25:169\u2013178. doi:\n10.1007\/s00296-004-0537-y","journal-title":"Rheumatol Int"},{"key":"3638_CR5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.rhu.0000173616.81928.44","volume":"11","author":"HIM Brunner","year":"2005","unstructured":"Brunner HIM, Johnson ALB, Barron AC et al (2005) Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: validation of a gastrointestinal symptom questionnaire. J Clin Rheumatol 11:194\u2013204","journal-title":"J Clin Rheumatol"},{"key":"3638_CR6","first-page":"480","volume":"25","author":"A Meer van der","year":"2007","unstructured":"van der Meer A, Wulffraat NM, Prakken BJ et al (2007) Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study. Clin Exp Rheumatol 25:480\u2013485","journal-title":"Clin Exp Rheumatol"},{"key":"3638_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1546-0096-11-23","volume":"11","author":"K Mulligan","year":"2013","unstructured":"Mulligan K, Kassoumeri L, Etheridge A et al (2013) Mothers\u2019 reports of the difficulties that their children experience in taking methotrexate for juvenile idiopathic arthritis and how these impact on quality of life. Pediatr Rheumatol Online J 11:23. doi:\n10.1186\/1546-0096-11-23","journal-title":"Pediatr Rheumatol Online J"},{"key":"3638_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-015-0052-6","author":"K Mulligan","year":"2015","unstructured":"Mulligan K, Wedderburn LR, Newman S (2015) The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people. Pediatr Rheumatol Online J. doi:\n10.1186\/s12969-015-0052-6","journal-title":"Pediatr Rheumatol Online J"},{"key":"3638_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1546-0096-12-S1-P 199","volume":"12","author":"ACD Silva","year":"2014","unstructured":"Silva ACD, Farias A, Sinicato N et al (2014) Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis. Pediatr Rheumatol 12:1\u20131. doi:\n10.1186\/1546-0096-12-S1-P 199","journal-title":"Pediatr Rheumatol"},{"key":"3638_CR10","first-page":"625","volume":"17","author":"A Ravelli","year":"1999","unstructured":"Ravelli A, Migliavacca D, Viola S et al (1999) Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. Clin Exp Rheumatol 17:625\u2013627","journal-title":"Clin Exp Rheumatol"},{"key":"3638_CR11","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3899\/jrheum.130738","volume":"41","author":"B Shea","year":"2014","unstructured":"Shea B, Swinden MV, Ghogomu ET et al (2014) Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. J Rheumatol 41:1049\u20131060. doi:\n10.3899\/jrheum.130738","journal-title":"J Rheumatol"},{"key":"3638_CR12","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/art.30367","volume":"63","author":"M Bulatovi\u0107","year":"2011","unstructured":"Bulatovi\u0107 M, Heijstek MW, Verkaaik M et al (2011) High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score. Arthritis Rheum 63:2007\u20132013. doi:\n10.1002\/art.30367","journal-title":"Arthritis Rheum"},{"key":"3638_CR13","doi-asserted-by":"publisher","first-page":"R217","DOI":"10.1186\/ar4413","volume":"15","author":"MB \u0106alasan","year":"2013","unstructured":"\u0106alasan MB, van den Bosch OF, Creemers MC et al (2013) Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis. Arthritis Res Ther 15:R217. doi:\n10.1186\/ar4413","journal-title":"Arthritis Res Ther"},{"key":"3638_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205265","author":"EHP Dijkhuizen van","year":"2014","unstructured":"van Dijkhuizen EHP, Wulffraat NM (2014) Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review. Ann Rheum Dis. doi:\n10.1136\/annrheumdis-2014-205265","journal-title":"Ann Rheum Dis"},{"key":"3638_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12969-015-0002-3","volume":"13","author":"EH Dijkhuizen van","year":"2015","unstructured":"van Dijkhuizen EH, \u0106alasan MB, Pluijm SM et al (2015) Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study. Pediatr Rheumatol 13:5. doi:\n10.1186\/s12969-015-0002-3","journal-title":"Pediatr Rheumatol"},{"key":"3638_CR16","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1097\/00007632-200012150-00014","volume":"25","author":"DE Beaton","year":"2000","unstructured":"Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25:3186\u20133191","journal-title":"Spine"},{"key":"3638_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1365-2753.2010.01434.x","volume":"17","author":"VD Sousa","year":"2011","unstructured":"Sousa VD, Rojjanasrirat W (2011) Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval Clin Pract 17:268\u2013274. doi:\n10.1111\/j.1365-2753.2010.01434.x","journal-title":"J Eval Clin Pract"},{"key":"3638_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, Grove A, Martin M et al (2005) Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 8:94\u2013104. doi:\n10.1111\/j.1524-4733.2005.04054.x","journal-title":"Value Health"},{"key":"3638_CR19","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"3638_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SDM, de Boer MR et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:34\u201342. doi:\n10.1016\/j.jclinepi.2006.03.012","journal-title":"J Clin Epidemiol"},{"issue":"i\u2013iv","key":"3638_CR21","first-page":"1","volume":"2","author":"R Fitzpatrick","year":"1998","unstructured":"Fitzpatrick R, Davey C, Buxton MJ, Jones DR (1998) Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess Winch Engl 2(i\u2013iv):1\u201374","journal-title":"Health Technol Assess Winch Engl"},{"key":"3638_CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"3638_CR23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s10067-016-3243-8","volume":"35","author":"N Fatimah","year":"2016","unstructured":"Fatimah N, Salim B, Nasim A et al (2016) Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire). Clin Rheumatol 35:1341\u20131345. doi:\n10.1007\/s10067-016-3243-8","journal-title":"Clin Rheumatol"},{"key":"3638_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12969-016-0099-z","volume":"14","author":"J Fr\u00e1\u0148ov\u00e1","year":"2016","unstructured":"Fr\u00e1\u0148ov\u00e1 J, Fingerhutov\u00e1 \u0160, Kobrov\u00e1 K et al (2016) Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration. Pediatr Rheumatol Online J 14:36. doi:\n10.1186\/s12969-016-0099-z","journal-title":"Pediatr Rheumatol Online J"},{"key":"3638_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12969-016-0071-y","volume":"14","author":"A Scheuern","year":"2016","unstructured":"Scheuern A, Fischer N, McDonald J et al (2016) Mutations in the MTHFR gene are not associated with methotrexate intolerance in patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J 14:11. doi:\n10.1186\/s12969-016-0071-y","journal-title":"Pediatr Rheumatol Online J"},{"key":"3638_CR26","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/art.1780371209","volume":"37","author":"G Singh","year":"1994","unstructured":"Singh G, Athreya BH, Fries JF, Goldsmith DP (1994) Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 37:1761\u20131769. doi:\n10.1002\/art.1780371209","journal-title":"Arthritis Rheum"},{"key":"3638_CR27","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/cncr.21871","volume":"106","author":"KMW Russell","year":"2006","unstructured":"Russell KMW, Hudson M, Long A, Phipps S (2006) Assessment of health-related quality of life in children with cancer: consistency and agreement between parent and child reports. Cancer 106:2267\u20132274. doi:\n10.1002\/cncr.21871","journal-title":"Cancer"},{"key":"3638_CR28","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s11136-004-7710-3","volume":"14","author":"MG Sawyer","year":"2005","unstructured":"Sawyer MG, Carbone JA, Whitham JN et al (2005) The relationship between health-related quality of life, pain, and coping strategies in juvenile arthritis\u2014a one year prospective study. Qual Life Res 14:1585\u20131598. doi:\n10.1007\/s11136-004-7710-3","journal-title":"Qual Life Res"},{"key":"3638_CR29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/0115426505020004411","volume":"20","author":"K Robien","year":"2005","unstructured":"Robien K (2005) Folate during antifolate chemotherapy: what we know... and do not know. Nutr Clin Pract 20:411\u2013422. doi:\n10.1177\/0115426505020004411","journal-title":"Nutr Clin Pract"},{"key":"3638_CR30","first-page":"547","volume":"75","author":"MJ Dolgin","year":"1985","unstructured":"Dolgin MJ, Katz ER, McGinty K, Siegel SE (1985) Anticipatory nausea and vomiting in pediatric cancer patients. Pediatrics 75:547\u2013552","journal-title":"Pediatrics"},{"key":"3638_CR31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/clpt.1987.142","volume":"42","author":"MG Myers","year":"1987","unstructured":"Myers MG, Cairns JA, Singer J (1987) The consent form as a possible cause of side effects. Clin Pharmacol Ther 42:250\u2013253","journal-title":"Clin Pharmacol Ther"},{"key":"3638_CR32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/jama.287.5.622","volume":"287","author":"AJ Barsky","year":"2002","unstructured":"Barsky AJ, Saintfort R, Rogers MP, Borus JF (2002) Nonspecific medication side effects and the nocebo phenomenon. JAMA 287:622\u2013627. doi:\n10.1001\/jama.287.5.622","journal-title":"JAMA"},{"key":"3638_CR33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/PSY.0b013e3182294a50","volume":"73","author":"L Colloca","year":"2011","unstructured":"Colloca L, Miller FG (2011) The nocebo effect and its relevance for clinical practice. Psychosom Med 73:598\u2013603. doi:\n10.1097\/PSY.0b013e3182294a50","journal-title":"Psychosom Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3638-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3638-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3638-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T05:09:26Z","timestamp":1496380166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3638-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["3638"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3638-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,5]]}}}